Brintellix, 5 mg 28 pcs.

Depression Treatment of major depressive disorder in adults.

Indications

Treatment of major depressive disorder in adults.

Pharmacological effect

Pharmacokinetics

Active ingredient

Vortioxetine

Composition

Active substance:

Side Effects

The most common adverse reaction was nausea.

Interaction

Vortioxetine is metabolized in the liver mainly by oxidation and subsequent conjugation with glucuronic acid. In vitro, the cytochrome P450 isoenzymes CYP2D6, CYP3A4/5, CYP2C19, CYP2C9, CYP2A6, CYP2C8 and CYP2B6 are involved in the metabolism of vortioxetine.

Overdose

Experience is limited.

Recommendations for use

Inside, regardless of food intake.

Manufacturer

H. Lundbeck A/O, Denmark